Get started
BAVARIAN NORDIC ASBAVARIAN NORDIC ASBAVARIAN NORDIC AS

BAVARIAN NORDIC AS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BAVA chart


Full chart

BAVA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.74 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
13.11
Basic EPS (TTM)
1.68 EUR
Net income (FY)
‪132.08 M‬ EUR
Revenue (FY)
‪763.47 M‬ EUR
Shares float
‪77.51 M‬
Beta (1Y)
0.42

Employees


Employees (FY)
‪1.61 K‬
Change (1Y)
+232 +16.82%
Revenue / Employee (1Y)
‪473.91 K‬ EUR
Net income / Employee (1Y)
‪81.99 K‬ EUR

About BAVARIAN NORDIC A/S


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Paul Chaplin
Website
bavarian-nordic.com
Headquarters
Hellerup
Founded
1992
ISIN
DK0015998017
FIGI
BBG01C3N96K3
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BAVA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BAVA.

Frequently Asked Questions


The current price of BAVA is 21.93 EUR — it has decreased by −0.59% in the past 24 hours. Watch BAVARIAN NORDIC AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange BAVARIAN NORDIC AS stocks are traded under the ticker BAVA.
BAVA stock has fallen by −0.36% compared to the previous week, the month change is a −6.48% fall, over the last year BAVARIAN NORDIC AS has showed a 2.57% increase.
We've gathered analysts' opinions on BAVARIAN NORDIC AS future price: according to them, BAVA price has a max estimate of 40.18 EUR and a min estimate of 30.94 EUR. Watch BAVA chart and read a more detailed BAVARIAN NORDIC AS stock forecast: see what analysts think of BAVARIAN NORDIC AS and suggest that you do with its stocks.
BAVA reached its all-time high on Aug 16, 2024 with the price of 39.43 EUR, and its all-time low was 16.97 EUR and was reached on Oct 19, 2023. View more price dynamics on BAVA chart.
See other stocks reaching their highest and lowest prices.
BAVA stock is 1.52% volatile and has beta coefficient of 0.42. Track BAVARIAN NORDIC AS stock price on the chart and check out the list of the most volatile stocks — is BAVARIAN NORDIC AS there?
Today BAVARIAN NORDIC AS has the market capitalization of ‪1.73 B‬, it has increased by 3.62% over the last week.
Yes, you can track BAVARIAN NORDIC AS financials in yearly and quarterly reports right on TradingView.
BAVARIAN NORDIC AS is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
BAVARIAN NORDIC AS revenue for the last quarter amounts to ‪279.95 M‬ EUR, despite the estimated figure of ‪250.27 M‬ EUR. In the next quarter, revenue is expected to reach ‪125.68 M‬ EUR.
BAVA net income for the last quarter is ‪103.05 M‬ EUR, while the quarter before that showed ‪9.45 M‬ EUR of net income which accounts for 990.69% change. Track more BAVARIAN NORDIC AS financial stats to get the full picture.
No, BAVA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 22, 2025, the company has ‪1.61 K‬ employees. See our rating of the largest employees — is BAVARIAN NORDIC AS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NORDIC AS EBITDA is ‪215.47 M‬ EUR, and current EBITDA margin is 27.30%. See more stats in BAVARIAN NORDIC AS financial statements.
Like other stocks, BAVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NORDIC AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAVARIAN NORDIC AS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAVARIAN NORDIC AS stock shows the strong sell signal. See more of BAVARIAN NORDIC AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.